Stability of FDG-PET Radiomics features: An integrated analysis of test-retest and inter-observer variability
Abstract Purpose. Besides basic measurements as maximum standardized uptake value (SUV)max or SUVmean derived from 18F-FDG positron emission tomography (PET) scans, more advanced quantitative imaging features (i.e. "Radiomics" features) are increasingly investigated for treatment monitorin...
Gespeichert in:
Veröffentlicht in: | Acta oncologica 2013-10, Vol.52 (7), p.1391-1397 |
---|---|
Hauptverfasser: | , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1397 |
---|---|
container_issue | 7 |
container_start_page | 1391 |
container_title | Acta oncologica |
container_volume | 52 |
creator | Leijenaar, Ralph T. H. Carvalho, Sara Velazquez, Emmanuel Rios van Elmpt, Wouter J. C. Parmar, Chintan Hoekstra, Otto S. Hoekstra, Corneline J. Boellaard, Ronald Dekker, André L. A. J. Gillies, Robert J. Aerts, Hugo J. W. L. Lambin, Philippe |
description | Abstract
Purpose. Besides basic measurements as maximum standardized uptake value (SUV)max or SUVmean derived from 18F-FDG positron emission tomography (PET) scans, more advanced quantitative imaging features (i.e. "Radiomics" features) are increasingly investigated for treatment monitoring, outcome prediction, or as potential biomarkers. With these prospected applications of Radiomics features, it is a requisite that they provide robust and reliable measurements. The aim of our study was therefore to perform an integrated stability analysis of a large number of PET-derived features in non-small cell lung carcinoma (NSCLC), based on both a test-retest and an inter-observer setup. Methods. Eleven NSCLC patients were included in the test-retest cohort. Patients underwent repeated PET imaging within a one day interval, before any treatment was delivered. Lesions were delineated by applying a threshold of 50% of the maximum uptake value within the tumor. Twenty-three NSCLC patients were included in the inter-observer cohort. Patients underwent a diagnostic whole body PET-computed tomography (CT). Lesions were manually delineated based on fused PET-CT, using a standardized clinical delineation protocol. Delineation was performed independently by five observers, blinded to each other. Fifteen first order statistics, 39 descriptors of intensity volume histograms, eight geometric features and 44 textural features were extracted. For every feature, test-retest and inter-observer stability was assessed with the intra-class correlation coefficient (ICC) and the coefficient of variability, normalized to mean and range. Similarity between test-retest and inter-observer stability rankings of features was assessed with Spearman's rank correlation coefficient. Results. Results showed that the majority of assessed features had both a high test-retest (71%) and inter-observer (91%) stability in terms of their ICC. Overall, features more stable in repeated PET imaging were also found to be more robust against inter-observer variability. Conclusion. Results suggest that further research of quantitative imaging features is warranted with respect to more advanced applications of PET imaging as being used for treatment monitoring, outcome prediction or imaging biomarkers. |
doi_str_mv | 10.3109/0284186X.2013.812798 |
format | Article |
fullrecord | <record><control><sourceid>informahealthcare_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4533992</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_3109_0284186X_2013_812798</sourcerecordid><originalsourceid>FETCH-LOGICAL-c580t-beb4f74572cdadbeec10858db2bee98196f5b5068fe6b821d0c7499ea7b25eb63</originalsourceid><addsrcrecordid>eNp9kFtLwzAUx4Mobk6_gUi_QGeSNm3qgzDmNoWBohP2FpL2dMvoZSTZYN_e1l3UF5_O4eR_CT-EbgnuBwQn95jykPBo3qeYBH1OaJzwM9QlESM-pdH8HHVbid9qOujK2hXGmAYxu0QdGuIwDoK4i8oPJ5UutNt5de6Nnyb-22jmvctM16VOrZeDdBsD9sEbVJ6uHCyMdJB5spLFzmrbuhxY5xtoR3PPvmXGr5UFswXjbaXRh45rdJHLwsLNYfbQ53g0Gz7709fJy3Aw9VPGsfMVqDCPQxbTNJOZAkgJ5oxnijZ7wkkS5UwxHPEcIsUpyXAah0kCMlaUgYqCHnrc5643qoQshcoZWYi10aU0O1FLLf6-VHopFvVWhCwIkoQ2AeE-IDW1tQbyk5dg0eIXR_yixS_2-Bvb3e_ek-nI--djusprU8olyMItU2lArOqNaaDa_xu-AO2zmCU</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Stability of FDG-PET Radiomics features: An integrated analysis of test-retest and inter-observer variability</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Taylor & Francis Journals Complete</source><source>Alma/SFX Local Collection</source><creator>Leijenaar, Ralph T. H. ; Carvalho, Sara ; Velazquez, Emmanuel Rios ; van Elmpt, Wouter J. C. ; Parmar, Chintan ; Hoekstra, Otto S. ; Hoekstra, Corneline J. ; Boellaard, Ronald ; Dekker, André L. A. J. ; Gillies, Robert J. ; Aerts, Hugo J. W. L. ; Lambin, Philippe</creator><creatorcontrib>Leijenaar, Ralph T. H. ; Carvalho, Sara ; Velazquez, Emmanuel Rios ; van Elmpt, Wouter J. C. ; Parmar, Chintan ; Hoekstra, Otto S. ; Hoekstra, Corneline J. ; Boellaard, Ronald ; Dekker, André L. A. J. ; Gillies, Robert J. ; Aerts, Hugo J. W. L. ; Lambin, Philippe</creatorcontrib><description>Abstract
Purpose. Besides basic measurements as maximum standardized uptake value (SUV)max or SUVmean derived from 18F-FDG positron emission tomography (PET) scans, more advanced quantitative imaging features (i.e. "Radiomics" features) are increasingly investigated for treatment monitoring, outcome prediction, or as potential biomarkers. With these prospected applications of Radiomics features, it is a requisite that they provide robust and reliable measurements. The aim of our study was therefore to perform an integrated stability analysis of a large number of PET-derived features in non-small cell lung carcinoma (NSCLC), based on both a test-retest and an inter-observer setup. Methods. Eleven NSCLC patients were included in the test-retest cohort. Patients underwent repeated PET imaging within a one day interval, before any treatment was delivered. Lesions were delineated by applying a threshold of 50% of the maximum uptake value within the tumor. Twenty-three NSCLC patients were included in the inter-observer cohort. Patients underwent a diagnostic whole body PET-computed tomography (CT). Lesions were manually delineated based on fused PET-CT, using a standardized clinical delineation protocol. Delineation was performed independently by five observers, blinded to each other. Fifteen first order statistics, 39 descriptors of intensity volume histograms, eight geometric features and 44 textural features were extracted. For every feature, test-retest and inter-observer stability was assessed with the intra-class correlation coefficient (ICC) and the coefficient of variability, normalized to mean and range. Similarity between test-retest and inter-observer stability rankings of features was assessed with Spearman's rank correlation coefficient. Results. Results showed that the majority of assessed features had both a high test-retest (71%) and inter-observer (91%) stability in terms of their ICC. Overall, features more stable in repeated PET imaging were also found to be more robust against inter-observer variability. Conclusion. Results suggest that further research of quantitative imaging features is warranted with respect to more advanced applications of PET imaging as being used for treatment monitoring, outcome prediction or imaging biomarkers.</description><identifier>ISSN: 0284-186X</identifier><identifier>EISSN: 1651-226X</identifier><identifier>DOI: 10.3109/0284186X.2013.812798</identifier><identifier>PMID: 24047337</identifier><language>eng</language><publisher>England: Informa Healthcare</publisher><subject>Carcinoma, Non-Small-Cell Lung - diagnostic imaging ; Carcinoma, Non-Small-Cell Lung - pathology ; Carcinoma, Non-Small-Cell Lung - radiotherapy ; Fluorodeoxyglucose F18 ; Humans ; Lung Neoplasms - diagnostic imaging ; Lung Neoplasms - pathology ; Lung Neoplasms - radiotherapy ; Observer Variation ; Positron-Emission Tomography ; Prognosis ; Radiopharmaceuticals ; Radiotherapy Planning, Computer-Assisted ; Radiotherapy, Image-Guided ; Tomography, X-Ray Computed</subject><ispartof>Acta oncologica, 2013-10, Vol.52 (7), p.1391-1397</ispartof><rights>2013 Informa Healthcare 2013</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c580t-beb4f74572cdadbeec10858db2bee98196f5b5068fe6b821d0c7499ea7b25eb63</citedby><cites>FETCH-LOGICAL-c580t-beb4f74572cdadbeec10858db2bee98196f5b5068fe6b821d0c7499ea7b25eb63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.tandfonline.com/doi/pdf/10.3109/0284186X.2013.812798$$EPDF$$P50$$Ginformahealthcare$$H</linktopdf><linktohtml>$$Uhttps://www.tandfonline.com/doi/full/10.3109/0284186X.2013.812798$$EHTML$$P50$$Ginformahealthcare$$H</linktohtml><link.rule.ids>230,314,776,780,881,27901,27902,61194,61375</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24047337$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Leijenaar, Ralph T. H.</creatorcontrib><creatorcontrib>Carvalho, Sara</creatorcontrib><creatorcontrib>Velazquez, Emmanuel Rios</creatorcontrib><creatorcontrib>van Elmpt, Wouter J. C.</creatorcontrib><creatorcontrib>Parmar, Chintan</creatorcontrib><creatorcontrib>Hoekstra, Otto S.</creatorcontrib><creatorcontrib>Hoekstra, Corneline J.</creatorcontrib><creatorcontrib>Boellaard, Ronald</creatorcontrib><creatorcontrib>Dekker, André L. A. J.</creatorcontrib><creatorcontrib>Gillies, Robert J.</creatorcontrib><creatorcontrib>Aerts, Hugo J. W. L.</creatorcontrib><creatorcontrib>Lambin, Philippe</creatorcontrib><title>Stability of FDG-PET Radiomics features: An integrated analysis of test-retest and inter-observer variability</title><title>Acta oncologica</title><addtitle>Acta Oncol</addtitle><description>Abstract
Purpose. Besides basic measurements as maximum standardized uptake value (SUV)max or SUVmean derived from 18F-FDG positron emission tomography (PET) scans, more advanced quantitative imaging features (i.e. "Radiomics" features) are increasingly investigated for treatment monitoring, outcome prediction, or as potential biomarkers. With these prospected applications of Radiomics features, it is a requisite that they provide robust and reliable measurements. The aim of our study was therefore to perform an integrated stability analysis of a large number of PET-derived features in non-small cell lung carcinoma (NSCLC), based on both a test-retest and an inter-observer setup. Methods. Eleven NSCLC patients were included in the test-retest cohort. Patients underwent repeated PET imaging within a one day interval, before any treatment was delivered. Lesions were delineated by applying a threshold of 50% of the maximum uptake value within the tumor. Twenty-three NSCLC patients were included in the inter-observer cohort. Patients underwent a diagnostic whole body PET-computed tomography (CT). Lesions were manually delineated based on fused PET-CT, using a standardized clinical delineation protocol. Delineation was performed independently by five observers, blinded to each other. Fifteen first order statistics, 39 descriptors of intensity volume histograms, eight geometric features and 44 textural features were extracted. For every feature, test-retest and inter-observer stability was assessed with the intra-class correlation coefficient (ICC) and the coefficient of variability, normalized to mean and range. Similarity between test-retest and inter-observer stability rankings of features was assessed with Spearman's rank correlation coefficient. Results. Results showed that the majority of assessed features had both a high test-retest (71%) and inter-observer (91%) stability in terms of their ICC. Overall, features more stable in repeated PET imaging were also found to be more robust against inter-observer variability. Conclusion. Results suggest that further research of quantitative imaging features is warranted with respect to more advanced applications of PET imaging as being used for treatment monitoring, outcome prediction or imaging biomarkers.</description><subject>Carcinoma, Non-Small-Cell Lung - diagnostic imaging</subject><subject>Carcinoma, Non-Small-Cell Lung - pathology</subject><subject>Carcinoma, Non-Small-Cell Lung - radiotherapy</subject><subject>Fluorodeoxyglucose F18</subject><subject>Humans</subject><subject>Lung Neoplasms - diagnostic imaging</subject><subject>Lung Neoplasms - pathology</subject><subject>Lung Neoplasms - radiotherapy</subject><subject>Observer Variation</subject><subject>Positron-Emission Tomography</subject><subject>Prognosis</subject><subject>Radiopharmaceuticals</subject><subject>Radiotherapy Planning, Computer-Assisted</subject><subject>Radiotherapy, Image-Guided</subject><subject>Tomography, X-Ray Computed</subject><issn>0284-186X</issn><issn>1651-226X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kFtLwzAUx4Mobk6_gUi_QGeSNm3qgzDmNoWBohP2FpL2dMvoZSTZYN_e1l3UF5_O4eR_CT-EbgnuBwQn95jykPBo3qeYBH1OaJzwM9QlESM-pdH8HHVbid9qOujK2hXGmAYxu0QdGuIwDoK4i8oPJ5UutNt5de6Nnyb-22jmvctM16VOrZeDdBsD9sEbVJ6uHCyMdJB5spLFzmrbuhxY5xtoR3PPvmXGr5UFswXjbaXRh45rdJHLwsLNYfbQ53g0Gz7709fJy3Aw9VPGsfMVqDCPQxbTNJOZAkgJ5oxnijZ7wkkS5UwxHPEcIsUpyXAah0kCMlaUgYqCHnrc5643qoQshcoZWYi10aU0O1FLLf6-VHopFvVWhCwIkoQ2AeE-IDW1tQbyk5dg0eIXR_yixS_2-Bvb3e_ek-nI--djusprU8olyMItU2lArOqNaaDa_xu-AO2zmCU</recordid><startdate>20131001</startdate><enddate>20131001</enddate><creator>Leijenaar, Ralph T. H.</creator><creator>Carvalho, Sara</creator><creator>Velazquez, Emmanuel Rios</creator><creator>van Elmpt, Wouter J. C.</creator><creator>Parmar, Chintan</creator><creator>Hoekstra, Otto S.</creator><creator>Hoekstra, Corneline J.</creator><creator>Boellaard, Ronald</creator><creator>Dekker, André L. A. J.</creator><creator>Gillies, Robert J.</creator><creator>Aerts, Hugo J. W. L.</creator><creator>Lambin, Philippe</creator><general>Informa Healthcare</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20131001</creationdate><title>Stability of FDG-PET Radiomics features: An integrated analysis of test-retest and inter-observer variability</title><author>Leijenaar, Ralph T. H. ; Carvalho, Sara ; Velazquez, Emmanuel Rios ; van Elmpt, Wouter J. C. ; Parmar, Chintan ; Hoekstra, Otto S. ; Hoekstra, Corneline J. ; Boellaard, Ronald ; Dekker, André L. A. J. ; Gillies, Robert J. ; Aerts, Hugo J. W. L. ; Lambin, Philippe</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c580t-beb4f74572cdadbeec10858db2bee98196f5b5068fe6b821d0c7499ea7b25eb63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Carcinoma, Non-Small-Cell Lung - diagnostic imaging</topic><topic>Carcinoma, Non-Small-Cell Lung - pathology</topic><topic>Carcinoma, Non-Small-Cell Lung - radiotherapy</topic><topic>Fluorodeoxyglucose F18</topic><topic>Humans</topic><topic>Lung Neoplasms - diagnostic imaging</topic><topic>Lung Neoplasms - pathology</topic><topic>Lung Neoplasms - radiotherapy</topic><topic>Observer Variation</topic><topic>Positron-Emission Tomography</topic><topic>Prognosis</topic><topic>Radiopharmaceuticals</topic><topic>Radiotherapy Planning, Computer-Assisted</topic><topic>Radiotherapy, Image-Guided</topic><topic>Tomography, X-Ray Computed</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Leijenaar, Ralph T. H.</creatorcontrib><creatorcontrib>Carvalho, Sara</creatorcontrib><creatorcontrib>Velazquez, Emmanuel Rios</creatorcontrib><creatorcontrib>van Elmpt, Wouter J. C.</creatorcontrib><creatorcontrib>Parmar, Chintan</creatorcontrib><creatorcontrib>Hoekstra, Otto S.</creatorcontrib><creatorcontrib>Hoekstra, Corneline J.</creatorcontrib><creatorcontrib>Boellaard, Ronald</creatorcontrib><creatorcontrib>Dekker, André L. A. J.</creatorcontrib><creatorcontrib>Gillies, Robert J.</creatorcontrib><creatorcontrib>Aerts, Hugo J. W. L.</creatorcontrib><creatorcontrib>Lambin, Philippe</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Acta oncologica</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Leijenaar, Ralph T. H.</au><au>Carvalho, Sara</au><au>Velazquez, Emmanuel Rios</au><au>van Elmpt, Wouter J. C.</au><au>Parmar, Chintan</au><au>Hoekstra, Otto S.</au><au>Hoekstra, Corneline J.</au><au>Boellaard, Ronald</au><au>Dekker, André L. A. J.</au><au>Gillies, Robert J.</au><au>Aerts, Hugo J. W. L.</au><au>Lambin, Philippe</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Stability of FDG-PET Radiomics features: An integrated analysis of test-retest and inter-observer variability</atitle><jtitle>Acta oncologica</jtitle><addtitle>Acta Oncol</addtitle><date>2013-10-01</date><risdate>2013</risdate><volume>52</volume><issue>7</issue><spage>1391</spage><epage>1397</epage><pages>1391-1397</pages><issn>0284-186X</issn><eissn>1651-226X</eissn><abstract>Abstract
Purpose. Besides basic measurements as maximum standardized uptake value (SUV)max or SUVmean derived from 18F-FDG positron emission tomography (PET) scans, more advanced quantitative imaging features (i.e. "Radiomics" features) are increasingly investigated for treatment monitoring, outcome prediction, or as potential biomarkers. With these prospected applications of Radiomics features, it is a requisite that they provide robust and reliable measurements. The aim of our study was therefore to perform an integrated stability analysis of a large number of PET-derived features in non-small cell lung carcinoma (NSCLC), based on both a test-retest and an inter-observer setup. Methods. Eleven NSCLC patients were included in the test-retest cohort. Patients underwent repeated PET imaging within a one day interval, before any treatment was delivered. Lesions were delineated by applying a threshold of 50% of the maximum uptake value within the tumor. Twenty-three NSCLC patients were included in the inter-observer cohort. Patients underwent a diagnostic whole body PET-computed tomography (CT). Lesions were manually delineated based on fused PET-CT, using a standardized clinical delineation protocol. Delineation was performed independently by five observers, blinded to each other. Fifteen first order statistics, 39 descriptors of intensity volume histograms, eight geometric features and 44 textural features were extracted. For every feature, test-retest and inter-observer stability was assessed with the intra-class correlation coefficient (ICC) and the coefficient of variability, normalized to mean and range. Similarity between test-retest and inter-observer stability rankings of features was assessed with Spearman's rank correlation coefficient. Results. Results showed that the majority of assessed features had both a high test-retest (71%) and inter-observer (91%) stability in terms of their ICC. Overall, features more stable in repeated PET imaging were also found to be more robust against inter-observer variability. Conclusion. Results suggest that further research of quantitative imaging features is warranted with respect to more advanced applications of PET imaging as being used for treatment monitoring, outcome prediction or imaging biomarkers.</abstract><cop>England</cop><pub>Informa Healthcare</pub><pmid>24047337</pmid><doi>10.3109/0284186X.2013.812798</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0284-186X |
ispartof | Acta oncologica, 2013-10, Vol.52 (7), p.1391-1397 |
issn | 0284-186X 1651-226X |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4533992 |
source | MEDLINE; EZB-FREE-00999 freely available EZB journals; Taylor & Francis Journals Complete; Alma/SFX Local Collection |
subjects | Carcinoma, Non-Small-Cell Lung - diagnostic imaging Carcinoma, Non-Small-Cell Lung - pathology Carcinoma, Non-Small-Cell Lung - radiotherapy Fluorodeoxyglucose F18 Humans Lung Neoplasms - diagnostic imaging Lung Neoplasms - pathology Lung Neoplasms - radiotherapy Observer Variation Positron-Emission Tomography Prognosis Radiopharmaceuticals Radiotherapy Planning, Computer-Assisted Radiotherapy, Image-Guided Tomography, X-Ray Computed |
title | Stability of FDG-PET Radiomics features: An integrated analysis of test-retest and inter-observer variability |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T19%3A18%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-informahealthcare_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Stability%20of%20FDG-PET%20Radiomics%20features:%20An%20integrated%20analysis%20of%20test-retest%20and%20inter-observer%20variability&rft.jtitle=Acta%20oncologica&rft.au=Leijenaar,%20Ralph%20T.%20H.&rft.date=2013-10-01&rft.volume=52&rft.issue=7&rft.spage=1391&rft.epage=1397&rft.pages=1391-1397&rft.issn=0284-186X&rft.eissn=1651-226X&rft_id=info:doi/10.3109/0284186X.2013.812798&rft_dat=%3Cinformahealthcare_pubme%3E10_3109_0284186X_2013_812798%3C/informahealthcare_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/24047337&rfr_iscdi=true |